Sonnet BioTherapeutics Holdings, Inc. (SONN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 18.69M |
| Enterprise Value | 13.62M |
| P/E Ratio | -0.32 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 8.43 |
| Price/Book Ratio | 0.48 |
| Enterprise/Revenue | 3.36 |
| Enterprise/EBITDA | 37.59 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -16.11 |
| Operating Margin | -15.84 |
AD
Management Effectiveness
| Return On Assets | -1.08 |
| Return On Equity | -5.18 |
Income Statement
| Revenue | 1M |
| Revenue/Share | 0.25 |
| Gross Profit | 0 |
| EBITDA | 89,259 |
| Net Income | -16.11M |
| Diluted EPS | -3.95 |
Balance Sheet
| Total Cash | 5.12M |
| Total Cash/Share | 1.25 |
| Total Debt | 46,573 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.5 |
| Book Value Per Share | 2.64 |
Price History
| 52-Week Change | -21.25 |
| 52-Week High | 19.3 |
| 52-Week Low | 1.08 |
| Moving Average 50 Days | 4.58 |
| Moving Average 200 Days | 3.04 |
Statistics
| Average Volume | 1.11M |
| Shares Outstanding | 6.69M |
| % Held by Institutions | 610.28 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | September 30, 2024 |
AD
